# The MIND Study: Modifying the INcidence of Delirium

> **NCT00096863** · PHASE2 · COMPLETED · sponsor: **Vanderbilt University** · enrollment: 102 (actual)

## Conditions studied

- Delirium
- Cognition Disorders

## Interventions

- **DRUG:** Ziprasidone
- **DRUG:** Haloperidol
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00096863
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2016-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00096863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00096863, "The MIND Study: Modifying the INcidence of Delirium". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00096863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*